TI
SUPN icon

Turner Investments’s Supernus Pharmaceuticals SUPN Stock Holding History

Turner Investments’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,000
Closed -$216K – 206
2017
Q2 		$216K Sell
5,000
-2,000
-29% -$71.2K 0.14% 179
2017
Q1 		$219K Buy
+7,000
New +$188K 0.14% 176
2016
Q4 		– Sell
-28,000
Closed -$692K – 291
2016
Q3 		$692K Buy
+28,000
New +$634K 0.23% 130

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Turner Investments's SUPN Position: Q3 2017 in Review

Turner Investments sold out of Supernus Pharmaceuticals (SUPN) in Q3 2017, closing a stake of 5,000 shares — an estimated $216K sold.

Turner Investments first reported a position in SUPN in Q3 2016 and held it in 3 quarters. The position peaked at $692K in Q3 2016. 275 funds tracked by Wall St. Rank hold SUPN as of Q3 2017.

  • Turner Investments reported no remaining Supernus Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Turner Investments sold 5,000 Supernus Pharmaceuticals shares in Q3 2017, an estimated $216K.
  • Turner Investments first reported a position in Supernus Pharmaceuticals in Q3 2016 and held it in 3 quarters.
  • Turner Investments's Supernus Pharmaceuticals position peaked at $692K in Q3 2016.
  • 275 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2017.

Based on Turner Investments's 13F filing for Q3 2017, filed 8 Nov 2017.